Restricted Access

Before you enter

All products are sold strictly for in-vitro laboratory research — not for human consumption, therapeutic, or veterinary use.

Your confirmation is saved for 7 days. You will only be asked to confirm once per week.
By entering you accept full responsibility for compliance with all applicable laws.

For research use only  ·  Not for human or animal consumption
Home/Products/BPC-157/TB-500 (Wolverine)
BPC-157/TB-500 (Wolverine) research vial Third-party tested
Cellular Peptide Blend

BPC-157/TB-500 (Wolverine)

Wolverine Blend
BPC + TB4Regenerative Peptide StackBody Protection Compound + Thymosin Beta-4

A synergistic peptide combination designed to support tissue repair and regenerative processes through complementary cellular mechanisms in animal research models.

Price range: $65.00 through $120.00$6.50 / mg
Strength
Fast U.S. shippingFree on orders over $200
Third-party testedIndependent lab, every batch
Purity documentedHPLC + mass spec
Secure checkoutVenmo · Cash App · Zelle
01Research snapshot

BPC-157/TB-500 (Wolverine), by the numbers.

Structural and laboratory facts that define this compound. For laboratory research use only.

0
Compounds

BPC-157 + TB-500

0
BPC-157 residues

Synthetic pentadecapeptide

0
TB-500 residues

Thymosin β4 sequence

0:1
Blend ratio

10 mg = 5 + 5 · 20 mg = 10 + 10

02Mechanism of action

How it is studied.

Dual-peptide blend targeting complementary tissue repair pathways

01
BPC-157 Angiogenesis & Cytoprotection

BPC-157 upregulates VEGF expression and promotes new blood vessel formation, delivering nutrients and oxygen to damaged tissue. It also activates the NO system and demonstrates broad cytoprotective properties.

  • VEGF-mediated angiogenesis
  • Nitric oxide system modulation
  • Gastric and tissue cytoprotection
02
TB-500 Cell Migration & Actin Regulation

TB-500 sequesters G-actin monomers and promotes cytoskeletal remodeling, enabling repair cells to migrate to injury sites. It also activates integrin-linked kinase (ILK) for tissue repair signaling.

  • Actin-mediated cell migration
  • Integrin-linked kinase activation
  • Anti-fibrotic remodeling
03
Synergy Complementary Repair Cascade

BPC-157 initiates vascular support (blood flow to injury), while TB-500 mobilizes repair cells to the site. Together they address two distinct phases of tissue repair — perfusion and cellular migration.

  • Phase 1: Blood flow restoration (BPC-157)
  • Phase 2: Cell mobilization (TB-500)
  • Combined anti-inflammatory effects

Research pathway map

The primary pathways BPC-157/TB-500 (Wolverine) is investigated against in laboratory models.

BPC-157/TB-500 (Wolverine)TARGETS01BPC-15702TB-50003Synergy
Illustrative schematic based on published in-vitro and preclinical observations. Research use only.
03Specifications

Compound details.

Chemical nameBPC-157 + Thymosin β4 (TB-500)
SynonymsWolverine Blend, BPC + TB4, Regenerative Peptide Stack, Body Protection Compound + Thymosin Beta-4
FormLyophilized powder blend
DocumentationThird-party COA, per batch

Storage & handling

Supplied as a lyophilized powder. Store the sealed vial refrigerated at 2–8°C, protected from light and moisture; −20°C for long-term storage. Keep reconstituted material refrigerated.

FOR RESEARCH USE ONLYNot for human or animal consumption. Intended strictly for qualified researchers performing in-vitro or analytical laboratory work. No medical, diagnostic or therapeutic claims are made.
J Mol Med · 2017Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation

BPC-157 component: VEGFR2 signaling.

Hsieh MJ et al., 2017 · PubMed ↗
Expert Opin Biol Ther · 2012Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

TB-500 component: review of Thymosin β4 biology.

Goldstein AL et al., 2012 · PubMed ↗
0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Scroll to Top